Research Use Policy

Version 1.0.

This policy defines the laboratory work for which GPC offers its materials, purchaser qualifications, prohibited uses and responsibilities. It is a condition of catalogue access and every sale. Examples describe permitted purposes; they do not establish the suitability or regulatory status of a particular product.

Permitted context

GPC offers these materials solely for lawful, non-clinical laboratory research and supervised analytical teaching in Canada. The intended work concerns the material or an experimental laboratory system: its identity, composition, separation, measurement, stability or interactions. Any use as a reagent, test sample or laboratory comparator is subject to the qualifications and restrictions below.

GPC does not offer or supply these products for administration to humans or animals, clinical or diagnostic procedures, personal or household use, or incorporation into products intended for such uses. Analytical sample preparation, including dissolution, dilution, aliquoting and mixing for a permitted laboratory method, is distinct from preparing a product for administration. The latter is prohibited.

These restrictions describe GPC’s offer; they are not a regulatory approval, exemption or determination that a product is outside drug law. Classification depends on the actual product and the purposes for which it is manufactured, sold or represented, with applicable product-specific rules. A purchaser’s confirmation, institutional affiliation, product name, label or COA does not establish that a sale is lawful or remove GPC’s own legal obligations. GPC does not represent these products as authorized for human or veterinary use.

Examples of permitted laboratory work

  • Chromatography method development: investigate retention, selectivity, peak shape and separation of a chemically identified analyte using HPLC, UHPLC or another suitable separation method.
  • Mass-spectrometry characterization: investigate molecular ions, charge states, isotope patterns and fragmentation of an identified material, and develop acquisition or data-processing methods.
  • Analytical method evaluation: study specificity, response, working range, repeatability and intermediate precision; assess accuracy, detection or quantitation limits only with appropriate assigned values, controls and study design.
  • Sample-preparation studies: compare extraction, dilution, filtration, recovery and matrix effects using laboratory-prepared research samples and appropriately characterized controls.
  • Carryover and system-performance studies: evaluate blank response, wash procedures, retention-time drift and repeat measurements with a qualified test material. This does not mean any vial is an instrument manufacturer’s approved calibrant.
  • Stability and degradation research: measure chemical changes under controlled time, temperature, light, pH or storage conditions. Such studies do not establish an expiry date, sterility or safety for administration.
  • Container and surface studies: investigate adsorption, recovery and material loss involving research vials, filters, tubing or other laboratory contact surfaces.
  • Physicochemical characterization: investigate solubility, chemical composition or other measurable properties using an appropriate analytical method and independently verified material identity.
  • Non-clinical in vitro or cell-free research: use a suitable characterized material as an experimental reagent or comparator in biochemical or analytical systems. This permission does not establish biological activity or permit administration to a human or animal, a clinical trial, patient testing or a diagnostic result.
  • Method transfer and inter-laboratory comparison: compare results for traceable research samples across instruments, operators or qualified laboratories under a defined study plan. Transfer restrictions below continue to apply.
  • Supervised analytical teaching: teach separation, identification, measurement, uncertainty and laboratory recordkeeping with materials chosen through the institution’s risk assessment. Students handle material only with suitable training and supervision; purchasers and catalogue users must meet the separate age requirement.

Reference materials, calibration and suitability

These are examples of permitted work, conditional on legality, material identity and method suitability. They are not a statement that every catalogue item is appropriate for each method, commonly used as a standard, or validated for a particular application. Names referring to GLP, GH or another biological pathway identify compounds; they do not recommend an effect in people or animals.

Unless a product-specific document expressly establishes otherwise, GPC does not supply a certified reference material, pharmacopoeial reference standard, validated instrument calibrant, diagnostic reagent or material qualified for regulated product release. A purity percentage, nominal fill, molecular mass or COA alone does not establish assigned analyte concentration, traceability, measurement uncertainty, homogeneity or stability.

Before using material as an in-house reference, calibration point or quantitative control, the laboratory must qualify it for that particular method and establish the values and controls the method requires, using suitable independent reference materials where needed. Compare like chemical forms and account for counterions, water, other constituents and degradation. A stated blend ratio is not proof of the individual component concentrations or their separate suitability as controls.

No human, veterinary, therapeutic or clinical use

GPC does not intend the products for human or veterinary use and makes no warranty that any product is suitable for such use, or for any therapeutic, diagnostic, clinical, cosmetic or wellness purpose. The purchaser will not administer, inject, ingest, apply or otherwise use any product in or on a human or animal, will not represent that GPC has approved or recommended any such use, and will not ask GPC staff for dosing, reconstitution-for-administration, cycle, injection or outcome advice.

Qualified purchasers

Eligible purchasers include Canadian analytical laboratories, research organizations, research businesses, educational institutions and independent researchers who have suitable laboratory facilities and the training, supervision and authority needed for the actual work. A professional title, institutional email address or research-use checkbox alone does not establish qualification. A residential address or an individual account does not itself establish a suitable laboratory.

The purchaser confirms a genuine, specific, lawful laboratory purpose and responsibility for the material. If ordering for an organization, the purchaser must be authorized to commit that organization to the order and its restrictions. Work must be performed by technically qualified people or under their direct supervision. GPC may request an explanation of the intended analysis, end user, laboratory facilities or authority, and may decline, hold or cancel an order if a lawful research context cannot reasonably be established. Do not provide personal medical information as an explanation of research purpose.

Representations of qualification and intended use

The purchaser’s representations as to age, identity, qualifications, facilities, authority and intended laboratory-research use are conditions of catalogue access and of every sale. A false, incomplete or misleading representation, including a purchase for personal use dressed as research, a purchase on behalf of an unqualified person, or an intended human, veterinary, therapeutic or clinical use, is a material breach. GPC may then refuse, hold or cancel the order, terminate access, retain evidence as permitted by the Privacy Policy, and recover its losses. The defence and indemnity in the Terms applies to claims arising from such a representation or from any use outside this policy or the Restricted Use Policy.

Purchaser responsibilities

  • The purchaser and every person accessing the catalogue must be at least 21 years old.
  • The purchaser must have suitable facilities, training, controls and legal authority for the intended research.
  • The purchaser must treat every product as potentially hazardous. Before opening or handling it, the purchaser must review the product label and assess available information about the compound’s identity, properties and potential hazards, complete a compound- and procedure-specific risk assessment, and establish appropriate containment, engineering controls, personal protective equipment, access controls, incident procedures and lawful disposal. If identity, package integrity or required controls cannot be established, the purchaser must isolate the material, contact GPC and not open or use it. Many research compounds are not fully characterized, and the absence of a warning must never be read as an indication of safety.
  • The purchaser is responsible for safe receipt, inspection of labels and contents, storage, handling, recordkeeping, access security and disposal under applicable law and institutional requirements.
  • Products are for the purchaser’s permitted laboratory work. Except for transfer to a qualified analytical service provider solely to test the purchaser’s material for a permitted purpose, no resale or transfer outside the purchaser’s organization is allowed without GPC’s written agreement. The purchaser must communicate use restrictions and relevant hazard information, preserve identity and lot traceability during any sample preparation, and comply with packaging and transport requirements. GPC-funded testing remains subject to the Verification Program’s separate written pre-approval and evidence requirements. No agreement by GPC authorizes an unlawful transfer or a prohibited use.

Inspection, variation and allocation of risk

Inspect identity, lot, quantity and condition on receipt and report discrepancies under the Refund & Return Policy. Quarantine material with uncertain identity or an unexplained discrepancy until resolved. Published analyses describe the tested sample under the reported method and do not establish the performance of every vial. This does not displace the express product-identity warranty in the Terms or any mandatory legal right.

The purchaser must assess the selected material, method, exposure controls, storage and disposal for its actual project before use. Research materials can present incompletely characterized hazards and variable analytical behaviour. To the extent permitted by law, the purchaser accepts the risks of its own selection and research activities and activities under its control, subject to GPC’s express obligations and liabilities that cannot lawfully be excluded.

Custody after delivery

After delivery, the purchaser controls the material’s storage, handling, security and chain of custody. Because GPC cannot verify those conditions once a shipment leaves its custody, a shipped vial is not accepted for restocking or resale. Any remedy based on purchaser-arranged laboratory testing is governed only by the GPC Verification Program Terms and is not a general representation about every unit or lot.

No protocols or outcomes

Glacier Pure Compounds does not provide dosing, administration or treatment protocols and makes no claim about biological, therapeutic, diagnostic or performance outcomes. Product identity and documentation fields do not expand the permitted use. Support is limited to catalogue facts, formats, pricing, order status, shipping and lot records.

Confirmation and changes

Access and checkout require an affirmative research-use confirmation. The accepted policy version, language and content hash are retained with the evidence record. A material revision requires a new confirmation.